AAAAAA

   
Results: 1-25 | 26-39 |
Results: 26-39/39

Authors: Takemasa, A Yorioka, N
Citation: A. Takemasa et N. Yorioka, Interleukin-1 beta and recombinant human erythropoietin therapy, CLIN NEPHR, 52(1), 1999, pp. 61-62

Authors: Yorioka, N Taniguchi, Y Amimoto, D Miyata, H Yamakido, M Taguchi, T
Citation: N. Yorioka et al., Chronic rheumatoid arthritis complicated by myeloperoxidase antineutrophilcytoplasmic antibody-associated nephritis, AM J NEPHR, 19(4), 1999, pp. 527-529

Authors: Oda, H Yorioka, N Ueda, C Kushihata, S Yamakido, M
Citation: H. Oda et al., Apolipoprotein E polymorphism and renal disease, KIDNEY INT, 56, 1999, pp. S25-S27

Authors: Nishida, Y Oda, H Yorioka, N
Citation: Y. Nishida et al., Effect of lipoproteins on mesangial cell proliferation, KIDNEY INT, 56, 1999, pp. S51-S53

Authors: Taniguchi, Y Yorioka, N Masaki, T Asakimori, Y Yamashita, K Yamakido, M
Citation: Y. Taniguchi et al., Localization of transforming growth factors beta 1 and beta 2 and epidermal growth factor in IgA nephropathy, SC J UROL N, 33(4), 1999, pp. 243-247

Authors: Shao, JC Yorioka, N Nishida, Y Yamakido, M
Citation: Jc. Shao et al., Effect of pH and glucose on cultured human peritoneal mesothelial cells, SC J UROL N, 33(4), 1999, pp. 248-256

Authors: Yorioka, N Nishida, Y Oda, H Watanabe, T Yamakido, M
Citation: N. Yorioka et al., Apolipoprotein E polymorphism in IgA nephropathy, NEPHRON, 83(3), 1999, pp. 246-249

Authors: Yorioka, N Taniguchi, Y Okushin, S Amimoto, D Kataoka, K Taguchi, T
Citation: N. Yorioka et al., Classic polyarteritis nodosa associated with renal amyloidosis, NEPHRON, 82(1), 1999, pp. 93-94

Authors: Taniguchi, Y Yorioka, N Katsutani, M Nagano, R Yokoyama, R Okubo, M Yamakido, M
Citation: Y. Taniguchi et al., Hemophagocytic syndrome in a patient with Hashimoto's thyroiditis and membranous nephritis, NEPHRON, 81(2), 1999, pp. 246-247

Authors: Taniguchi, Y Yorioka, N Kumagai, J Katsutani, M Kuratsune, M Amimoto, D Yamakido, M
Citation: Y. Taniguchi et al., Interleukin-6 localization and the prognosis of IgA nephropathy, NEPHRON, 81(1), 1999, pp. 94-98

Authors: Taniguchi, Y Yorioka, N Yamashita, K Masaki, T Yamakido, M
Citation: Y. Taniguchi et al., Transforming growth factor-beta(1) may be involved in shunt obstruction inpatients on chronic hemodialysis, NEPHRON, 81(1), 1999, pp. 102-105

Authors: Ogawa, T Hayashi, T Kyoizumi, S Ito, T Trosko, JE Yorioka, N
Citation: T. Ogawa et al., Up-regulation of gap junctional intercellular communication by hexamethylene bisacetamide in cultured human peritoneal mesothelial cells, LAB INV, 79(12), 1999, pp. 1511-1520

Authors: Yorioka, N Taniguchi, Y Yamashita, K Ueda, C Nakamura, C Harada, S Yamakido, M
Citation: N. Yorioka et al., Tissue factor and tissue factor pathway inhibitor in hemodialysis patients, INT J ARTIF, 21(11), 1998, pp. 699-701

Authors: Nishida, Y Shao, JC Kiribayashi, K Nakamura, C Yorioka, N
Citation: Y. Nishida et al., Advanced glycation end-products reduce the viability of human peritoneal mesothelial coils, NEPHRON, 80(4), 1998, pp. 477-478
Risultati: 1-25 | 26-39 |